학술논문

Lymphadenopathy after the third Covid-19 vaccine
Document Type
article
Source
Current Problems in Cancer: Case Reports, Vol 4, Iss , Pp 100127- (2021)
Subject
Covid 19
vaccine
vaccination
booster
lymphadenopathy
mRNA
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2666-6219
Abstract
Summary: Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.